Gyre Therapeutics, Inc. GYRE Gross margin

Gross margin at other companies

Eli LillyLLY

83.4%+0.8pp

Madrigal Pharmaceuticals, Inc.MDGL

96.5%—

Rigel PharmaceuticalsRIGL

93.4%+3.7pp

Zevra Therapeutics, Inc.ZVRA

95.5%+23.5pp

LQD

Liquidia CorporationLQDA

58.1%-18.7pp

BridgeBio PharmaBBIO

94.4%-1.8pp

FAQ

What is Gyre Therapeutics, Inc.'s gross margin?

Gyre Therapeutics, Inc. (GYRE) reported gross margin of 94.3% in Q2 2026.

How has Gyre Therapeutics, Inc.'s gross margin changed year-over-year?

Gyre Therapeutics, Inc.'s gross margin decreased by 1.8% year-over-year, from 96% to 94.3%.

What is the long-term trend for Gyre Therapeutics, Inc.'s gross margin?

Over 2 years (2023 to 2025), Gyre Therapeutics, Inc.'s gross margin has grown at a -0.2% compound annual growth rate (CAGR), from 95.9% to 95.5%.

What does gross margin mean?

Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.